Annals of Oncology Advance Access originally published online on September 13, 2009
Annals of Oncology 2009 20(11):1901-1902; doi:10.1093/annonc/mdp451
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
letters to the editor |
Nasal septum perforation in a breast cancer patient treated with bevacizumab
| The first 10% of the full text of this article appears below. |
A 39-year-old woman was diagnosed in January 2009 of a supraclavicular and pulmonary relapse of breast cancer. Two years earlier, in February 2007, she had been diagnosed of a left breast cancer, staged as T2N0M0, negative for both hormone receptors and Her2/neu. After surgical treatment with tumorectomy and axillary lymphadenectomy, she received adjuvant therapy
Department of Medical Oncology, University Hospital La Paz, Madrid, Spain
* (E-mail: alvaro_pinto_marin@hotmail.com)